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Background
Interference of clinical laboratory assays by endogenous
& exogenous substances in the blood is well known. To
date, there are no clear guidelines on the testing of lipe-
mic or bilirubinemic (icteric) plasma in clinical labora-
tories. A conservative approach of alerting the physician
with re-sampling and/or processing with caution is
advised. This study focuses on the effect of processed
(2005-2010) HIV-1 lipemic or icteric patient plasma
(visual inspection) on genotyping (virco®TYPE HIV-1)
and phenotyping (Antivirogram®) success at Virco.
Materials and methods
The viral RNA extraction kits (QiaAmp Virus MDx kit:
965652 or Easymag Nuclisens: 280130-280135) are
highly sensitive in deriving intact, good quality RNA
from lipemic or icteric plasma, leading to successful
amplification of PR- RT genes. The validity of the
obtained result was confirmed by comparing the results
from previous or subsequent visits/services from the
same patient, where available.
Results
Between 2005-2010, 569 lipemic (0.97% of total samples
received) samples were processed. From the 510 geno-
type requests, 408 were successfully genotyped (positive
& 265 had viral load (VL) >1000 cp/ml) and 102 failed
(negative, 39 samples with VL <1000 cp/ml, 35
unknown VL & 28 with VL >1000 cp/ml). From the 335
phenotype requests, 267 were positive & 68 negative (36
w i t hV L < 1 0 0 0c p / m l ,1 6u n k n o w nV L&1 6w i t hV L
>1000 cp/ml). From 2005-2010, 417 icteric (0.71% of
total samples received) samples were processed. From
the 394 genotype requests, 367 were positive (301 had
VL >1000 cp/ml) & 27 negative (9 with VL<1000 cp/ml,
12 unknown VL & 6 with VL >1000 cp/ml). From the
166 phenotype requests, 153 were positive & 13 were
negative (3 with VL<1000 cp/ml, 6 unknown VL & 4
with VL >1000 cp/ml).
Conclusions
No limitations were observed for the different Clades.
The success rate for lipemic samples (265/293) & icteric
samples (301/307) with VL >1000 cp/ml was 90% &
98% respectively, indicating that both lipemic and icteric
samples can be processed for resistance testing using
our genotyping and phenotyping assays, under circum-
stances where re-sampling is difficult. The sensitivity to
phenotyping clearly demonstrates the integrity of the
amplified product that can be used to generate viable
recombinant virus stocks.
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